Deals this week: IsoRay, ClearLight Diagnostics, IntriCon

11 May 2018 (Last Updated May 11th, 2018 14:14)

IsoRay Inc plans to issue shares of its common stock to raise more than $8.5m.

IsoRay Inc plans to issue shares of its common stock to raise more than $8.5m.

Based in the US, IsoRay develops and commercialises isotope-based drugs and devices.

The company plans to use the funds towards general corporate purposes.

HC Wainwright and Co was appointed as an underwriter, while Gallagher and Kennedy PA was selected as the legal advisor for the transaction.

ClearLight Diagnostics LLC has raised $2.77m in a venture funding round led by existing investor CS Investors LLC.

The financing round also involved participation from Pivotal Paramount Investment and Stanford University.

Based in the US, ClearLight is involved in the development of next-generation tissue processing, as well as a 3D imaging platform for research and diagnostic purposes.

The company is set to use the funds towards the continued development of its automated platform.

IntriCon Corp (IntriCon) plans to issue securities in one or more offerings to raise $30m.

Based in the US, IntriCon is a developer and manufacturer of miniature and micro-miniature body-worn medical and electronics products.

The company plans to use the funds for repayment of bank loans, working capital and other general corporate purposes.

MicroBase Technology Corp is planning to raise TW$150m ($5.05m) by issuing 15 million shares priced at TW$10 ($0.337) each.

Based in Taiwan, MicroBase Technology is involved in the development and manufacturing of miniaturised devices and micron-scale parts and systems.

The company proposes to use the proceeds to expand production capacity and strengthen its financial structure.

Bovie Medical Corporation is to raise $25m through a public offering of securities.

“The company plans to use the funds towards the development of its neonatal screening technology.”

The company plans to use funds for the repayment of debts, acquisition of complementary products, working capital and other general corporate purposes.

Ruskin Moscou Faltischek PC has been appointed as the legal advisor for the offering.

Baebies Inc has raised $13m in an equity financing round led by Rex Health Ventures, Duke Angel Network, and DUMAC.

Based in the US, Baebies is a developer of newborn screening and paediatric testing products.

The company plans to use the funds towards the development of its neonatal screening technology.

Entac Medical Inc has raised funds through a series A2 financing round from Innova Memphis Inc.

Investors iSelect Fund Management LLC and Sage Fund LP also participated in the funding round.

The proceeds from the offering are proposed to be used to complete the development of Entac’s non-invasive patented technology, PrevisEA.

Based in the US, Entac is a developer of medical devices for predictive and diagnostic medicine.

ICARES Medicus Inc plans to raise TWD110.5m ($3.69m) through a public offering of 2.57 million shares priced at TWD43 ($1.44) each.

The company plans to issue 0.28 million shares, of which 0.028 million shares are meant for its employees and the remaining 0.25 million shares to be issued to the company’s shareholders.

Based in Taiwan, ICARES supplies ophthalmic products.

The company intends to use the funds towards general corporate purposes.

Phygen LLC plans to issue equity securities to raise funds in a venture financing round.

Based in the US, Phygen is a spinal surgery systems developer.